Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554510 · ClinicalTrials.gov registry record
Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 757
- Enrollment target
NCT05554510: Completed study, sponsored by University of California, San Francisco.
NCT05554510 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 757 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05554510 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 757 participants
- Enrollment target
Study Summary
This is a prospective observational study designed to quantify and understand errors in pulse oximetry in hospitalized patients in relation to their skin pigmentation. It is driven by three recent retrospective studies showing missed diagnosis of hypoxemia in patients across a spectrum of skin pigmentation, defined as blood SaO2 \<90% when their pulse oximeter reads 92% or greater.
Primary Outcome
Pulse oximeter bias (difference between SpO2 and SaO2)
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 757 participants |
| Start Date | 2022-08-14 |
| Est. Completion | 2024-08-20 |
What the finished NCT05554510 record still lists
NCT05554510 is an observational study that tracks outcomes without assigning an intervention. The registered 757 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT05554510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05554510 about?
NCT05554510 is a clinical study titled "Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation". This is a prospective observational study designed to quantify and understand errors in pulse oximetry in hospitalized patients in relation to their skin pigmentation. It is driven by three recent retrospective studies showing missed diagnosis of hypoxemia in patients across a spectrum of skin pigme...
What is the current status of trial NCT05554510?
This trial is currently completed. The enrollment target is 757 participants. The study started on 2022-08-14. Estimated completion is 2024-08-20.
What interventions are being tested in trial NCT05554510?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT05554510?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI